James Heppell Insider Profile
4 Followers
James Heppell, Director at Skye Bioscience, holds 500.00K shares in Skye Bioscience (Ticker: SKYE), holds 0.00 shares in Sophiris Bio (Ticker: SPHS). Most recently, James Heppell Bought ― shares of Skye Bioscience on Aug 11, 2020 for an estimated value of $25.00B.
James Heppell's Trading History
| SKYESkye Bioscience | Aug 11, 2020 | Director | Informative Buy | 25.00B | $495.00K | |
| SPHSSophiris Bio | Oct 31, 2016 | ― | Uninformative Buy | ― | $0.00 |
You May Also Like
James Heppell insider profile FAQ
What is the percentage of profitable transactions made by James Heppell?
The percentage of profitable transactions made by James Heppell is 100%.
What is the average return per transaction made by James Heppell?
The average return per transaction made by James Heppell is 125.20%.
What stocks does James Heppell hold?
James Heppell holds: SKYE, SPHS stocks.
What was James Heppell’s latest transaction?
James Heppell’s latest transaction was an Informative Buy of $25.00B.
What was James Heppell's most profitable transaction?
James Heppell’s most profitable transaction was an Informative Buy of SKYE stock on August 11, 2020. The return on the trade was 195.00%.
What is James Heppell's role in Skye Bioscience?
James Heppell's role in Skye Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
